{"title":"Automatic control of arterial blood pressure: computer, benchtop, and animal models.","authors":"Raghav Sriram, Bijan Abar, Siri Gullapalli, Yuhe Hu, Akshar Patel, Joshua Seth Broder","doi":"10.3389/fmedt.2026.1955568","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1955568","url":null,"abstract":"<p><strong>Background: </strong>Timely, accurate, and stable control of blood pressure (BP) in critical illness is essential for good clinical outcomes. The current clinical standard entails human operators intervening between the monitor and infusion pump, introducing delay, potential error, and risk of over- and undershoot of therapeutic goals. We developed and tested a closed-loop, automatic control system for BP using computer, benchtop, and animal models.</p><p><strong>Methods: </strong>All models employed a proportional-integral-derivative (PID) algorithm to control mean arterial pressure (MAP). The three components are summed to determine the final output, corresponding to the infusion rate of fluids or vasoactive drugs. The computer model simulated an automatically controlled drug infusion to regulate MAP. The benchtop model added physical components (clinical cardiac monitor, microcontroller, medication pump, and pressure transducer), adjusting the hydrostatic pressure in a closed system to meet a target. In the animal model, the MAP of anesthetized swine undergoing surgery was regulated using an automatically controlled norepinephrine or clevidipine infusion. For the animal model, statistical inference and comparison between trials could not be made given the sequential, non-independent design; quantities are descriptive only, not inferential. We applied common control system metrics including rise time, settling time, and on-target percentage (OTP).</p><p><strong>Results: </strong>The computer model rapidly reached and maintained target MAP ± 5 mmHg with OTP of 90% (95% CI 89.4%, 90.6%) at 240 simulated seconds (ss) and 95% (95% CI 94.6%, 95.4%) at 294 ss. The benchtop system reached and maintained target MAP with a mean rise time of 0.47 ± SD 0.15 min, mean settling time of 0.62 ± SD 0.18 min, and mean OTP (using a tolerance of MAP ± 5 mmHg) of 91.25 ± 9.68%. In a swine model, automatic norepinephrine augmented MAP by > 15 mmHg with mean rise time of 2.25 (SD 0.65) min and mean OTP of 56.9% (SD 22.7%). No trial maintained an equilibrium value of target MAP ± 5 mmHg; therefore, no settling time could be calculated. Clevidipine decreased MAP by >15 mmHg with mean rise time of 1.00 (SD 0.40) min, mean settling time of 2.19 (SD 1.45) min, and mean OTP of 93.8% (SD 7.18%). The results of the swine model were confounded by concurrent non-survival surgery. Within this limitation, the swine model demonstrated that the automatic control system was technically feasible.</p><p><strong>Conclusions: </strong>These proof-of-concept studies utilizing computer, benchtop, and animal models provide initial evidence that an automatic PID algorithm has potential to control BP across a range of starting BP. Future studies can optimize the system and compare its performance with human operators in advance of potential human clinical trials.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1955568"},"PeriodicalIF":4.6,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13716810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A systematic review of non-contact medical IoT systems for physiological biomarker monitoring.","authors":"Bithi Banik, Saptanil Ghose, Ahnaf Hasnain Nahiun, Yuan Lin, Andrii Shalaginov, Debasish Ghose","doi":"10.3389/fmedt.2026.1917332","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1917332","url":null,"abstract":"<p><strong>Introduction: </strong>Non-contact medical Internet of Things systems measure physiological biomarkers such as heart rate (HR), respiration rate (RR), temperature, oxygen saturation (SpO₂), and blood pressure (BP) without physical contact with the patient. These systems combine sensing modalities including cameras, radar, Wi-Fi, acoustic, and infrared sensors with signal processing and learning algorithms to deliver comfortable, non-invasive monitoring. Prior reviews have largely examined individual sensing modalities or signal processing techniques in isolation, leaving cross-modality system architecture and privacy-preserving design underexamined.</p><p><strong>Methods: </strong>We conducted a systematic review following PRISMA guidelines and analyzed 88 recent studies of non-contact monitoring systems. Studies were characterized by sensing modality, system architecture, target physiological parameter, validation setting, and reported performance. We additionally assessed each study for methodological quality and examined the extent to which privacy-preserving mechanisms were incorporated into system design.</p><p><strong>Results: </strong>Radar and vision-based systems dominate the corpus, together accounting for approximately three-quarters of included studies, while sound, Wi-Fi, embedded sensor, and mixed-modality designs remain at an earlier stage of validation. Research effort is heavily concentrated on two parameters: RR appears in 83% of studies and HR in 67%, while no other parameter exceeds 11%. BP, SpO₂, and temperature therefore remain largely unaddressed by contactless methods. Heterogeneous reporting metrics across studies prevent direct statistical comparison of performance between modalities.</p><p><strong>Discussion: </strong>The findings indicate that modality selection should be driven by deployment context rather than headline accuracy. Radar suits wards and intensive care units where patients are covered or moving, vision and sound suit structured clinical spaces with stable conditions, embedded sensor designs suit eldercare beds and chairs, and mixed radar and vision systems suit precision-critical settings such as neonatal and postoperative monitoring. Persistent challenges include signal reliability in uncontrolled environments, limited benchmarking due to the absence of standardized datasets, privacy and ethical concerns, and poor integration with existing healthcare infrastructure. Building on these insights, we propose a conceptual federated, edge-based learning framework, presented as a design proposal for future implementation rather than a validated system, and outline research directions to accelerate clinical translation.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1917332"},"PeriodicalIF":4.6,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13716870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Huixiu Han, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Theresa Tretter, Mandy Hinkelbein, Ann-Kathrin Bauer, Carsten Müller-Tidow, Michael Schmitt, Lei Wang
{"title":"A PBMC-based proof-of-principle framework for fit-for-purpose validation of flow cytometry assays in cell therapy development.","authors":"Huixiu Han, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Theresa Tretter, Mandy Hinkelbein, Ann-Kathrin Bauer, Carsten Müller-Tidow, Michael Schmitt, Lei Wang","doi":"10.3389/fmedt.2026.1905186","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1905186","url":null,"abstract":"<p><strong>Introduction: </strong>Cellular immunotherapy offers personalized therapeutic benefits but faces challenges such as manufacturing consistency and regulatory compliance. Validated analytical methods based on product's mechanism of action are essential to guarantee product quality and patient safety. Despite regulatory emphasis on analytical validation, a structured framework applicable to broader cellular therapies remains undefined.</p><p><strong>Methods: </strong>This study evaluated a PBMC-based proof-of-principle framework for fit-for-purpose validation of flow cytometry-based analytical method to cellular therapy development. Key assay parameters were optimized, including antibody concentration, photomultiplier tube (PMT) voltage, compensation, and steric hindrance verification. Assay validation assessed specificity, sensitivity, linearity, precision, robustness, and carryover across different conditions.</p><p><strong>Results: </strong>The validated method demonstrated high specificity (false-positive rates <1%), strong assay sensitivity (LLOQ within acceptable limits), robust linearity (R<sup>2</sup> > 0.9), and reproducibility across intra-assay, inter-instrument, and inter-operator evaluations. Practical considerations, including sample stability, antibody cocktail preparation, and instrument carryover, were also addressed to enhance workflow efficiency.</p><p><strong>Discussion: </strong>The proposed framework may support product-specific analytical method development; however, application to a defined cell therapy producet requires product-, matrix-, and analytical decision-specific qualification or validation.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1905186"},"PeriodicalIF":4.6,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13713653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Graziana M Ragonese, Edoardo Grosso, Dario Carbonaro, Elena Torta, Emiliano Lepore, Diego Gallo
{"title":"Biomechanical stabilization of the keratoconic cornea: a review of current therapeutic strategies.","authors":"Graziana M Ragonese, Edoardo Grosso, Dario Carbonaro, Elena Torta, Emiliano Lepore, Diego Gallo","doi":"10.3389/fmedt.2026.1919880","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1919880","url":null,"abstract":"<p><p>Keratoconus is a progressive corneal ectatic disorder characterized by stromal thinning and biomechanical weakening of the cornea, leading to progressive corneal protrusion and visual impairment. Therapeutic strategies have evolved from visual correction toward approaches specifically targeting the biomechanical instability underlying disease progression. This review provides a biomechanical perspective on current and emerging strategies for the biomechanical stabilization of the keratoconic cornea. Conservative treatments based on contact lenses remain essential for visual rehabilitation but do not modify the underlying ectatic process. Corneal collagen crosslinking represents the reference treatment for progressive keratoconus, as it increases stromal stiffness through the formation of additional covalent bonds. However, its efficacy depends on treatment protocol, epithelial status, corneal thickness, and disease stage. Corneal implants, i.e., synthetic intracorneal ring segments and corneal allogenic intrastromal ring segments, provide stretch-induced geometric improvement of the corneal shape and, consequently, of visual acuity, although predictability remains limited. Combined approaches, such as ring implantation followed by cross-linking, aim to integrate corneal reshaping with intrinsic stromal reinforcement. Emerging approaches, including cell-based therapies, and implantation of stromal lenticule or tissue-engineered scaffolds, suggest a future shift toward a multimodal therapeutic strategy integrating biomechanical stabilization, restoration of stromal structure, and biological regeneration. Advancing keratoconus management will require objective biomechanical assessment and predictive modeling tools to guide individualized treatment planning and improve outcome predictability. Ultimately, future management should increasingly incorporate a biomechanical perspective, with interventions designed to modify the mechanical behavior of the ectatic cornea, arrest progression, and restore functional corneal integrity.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1919880"},"PeriodicalIF":4.6,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13714491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Future of cardiac diffusion magnetic resonance imaging: a bibliometric analysis.","authors":"Xinyi Wu, Yuelong Yang, Yongzhou Xu, Zhigang Wu, Hui Liu, Rui Chen","doi":"10.3389/fmedt.2026.1801878","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1801878","url":null,"abstract":"<p><strong>Background: </strong>Cardiac diffusion magnetic resonance imaging (cDMRI) has become a valuable noninvasive tool for assessing cardiac microstructure.</p><p><strong>Objective: </strong>To perform a systematic and comprehensive bibliometric analysis of cDMRI to explore current status, research hotspots and potential future directions.</p><p><strong>Material and methods: </strong>A systematic search of Web of Science Core Collection (WoSCC) and PubMed was conducted to identify articles on cDMRI published between 2005 and 2024. All retrieved records were independently screened by two reviewers to exclude the articles unrelated to the topic about cDMRI. Co-citation, collaboration networks, burst keywords, and reference analyses were performed.</p><p><strong>Results: </strong>There were 359 articles searched in WoSCC and 88 articles in PubMed. Finally, 367 articles met the search criteria in both databases. The cardiac \"diffusion tensor imaging\" (cDTI) emerged as the most prominent keyword, with the highest occurrence count (191.0) and strongest citation bursts (6.8). The study by Nielles-Vallespin et al. showed the strongest citation burst (26.17), accumulating 163 total citations and an average of 20.38 citations per year, highlighting its substantial influence on the development of cDMRI research. The top-cited articles with the strongest citation bursts concentrated on the clinical application of cDTI, its sequence design, and cardiac electrophysiology based on cDTI. The trend topic analysis further revealed \"deep learning\" as an emerging research focus in cDMRI since 2022.</p><p><strong>Conclusions: </strong>To our knowledge, this is the first dedicated bibliometric analysis focusing on cDMRI. By systematically analyzing the current status, research hotspots, and future trends of cDMRI, it provided valuable insights to guide future investigations in this field.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1801878"},"PeriodicalIF":4.6,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13710368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149291270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmad Nasayreh, Nagham Osman, Laila Tahoun, Asem Mansour, Iyad Sultan
{"title":"MammoDiff: weakly supervised mammographic anomaly detection via classifier-guided denoising diffusion models-a real-world clinical study on the KHCC mammography cohort.","authors":"Ahmad Nasayreh, Nagham Osman, Laila Tahoun, Asem Mansour, Iyad Sultan","doi":"10.3389/fmedt.2026.1912196","DOIUrl":"10.3389/fmedt.2026.1912196","url":null,"abstract":"<p><strong>Introduction: </strong>Early detection of malignant mammographic lesions is a critical clinical challenge, particularly where large annotated datasets are unavailable. Supervised deep learning achieves near-radiologist performance but requires large datasets with reliable labels and pixel/ROI annotations. Weakly supervised anomaly detection, requiring only image-level binary labels, offers an annotation-efficient alternative, yet prior GAN- and autoencoder-based methods have struggled to preserve fine anatomical detail in the mammographic domain.</p><p><strong>Methods: </strong>We present MammoDiff, to our knowledge the first application of classifier-guided denoising diffusion models to weakly supervised mammographic anomaly detection, trained and evaluated on 3,013 mammograms from 806 patients at King Hussein Cancer Center (KHCC), Jordan. MammoDiff encodes input anatomy through deterministic DDIM noise encoding and reconstructs a counterfactual healthy image guided by the gradient signal of a noise-conditioned binary classifier. The anomaly map is the pixel-wise absolute difference between input and reconstruction, and the image-level score is obtained by spatial mean pooling. A 3 × 3 ablation over noise level <i>L</i> ∈ {250, 500, 750} and gradient scale <i>s</i> ∈ {50, 100, 200} was performed on the validation set.</p><p><strong>Results: </strong>The optimal configuration (<i>L</i> = 750, <i>s</i> = 50) achieved AUROC = 0.7246 [95% CI: 0.6685, 0.7825] on the held-out test set (<i>n</i> = 304), compared with a simplified PatchCore-style baseline (AUROC = 0.6634) and a supervised ResNet-50 reference (AUROC = 0.8100), without pixel-level annotation. The proposed Healthy-Shift Index (HSI) was positive for 94.8% of malignant and 87.4% of normal cases, so it is the separation between the class distributions rather than the sign of the index that carries information.</p><p><strong>Discussion: </strong>This performance is not clinically deployable: at the Youden-optimal threshold the sensitivity is 0.6013, meaning that 61 of 153 malignant cases are missed, well below the approximately 87% targeted by FDA-cleared triage devices, and the study is single-centre without external validation. MammoDiff is therefore presented as a methodological proof-of-concept and a reproducible baseline for future work, not as a screening or triage tool..</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1912196"},"PeriodicalIF":4.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13696467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149279035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A data-driven and interpretable hybrid quantum-classical model for male infertility risk assessment.","authors":"T Sarath, K Brindha","doi":"10.3389/fmedt.2026.1853728","DOIUrl":"10.3389/fmedt.2026.1853728","url":null,"abstract":"<p><strong>Introduction: </strong>Nearly 15% of couples worldwide experience infertility, with Male Infertility (MI) accounting for 30-50% of these cases. Despite this burden, research on MI lags behind female infertility, particularly in understanding how demographic, clinical, lifestyle, and environmental factors interact to shape reproductive outcomes. Traditional approaches typically examine isolated indicators and struggle to capture the high-dimensional, nonlinear patterns present in Electronic Health Record (EHR) data. This study proposes a data-driven, interpretable framework integrating global fertility rate trends with EHR-derived male fertility data to (i) identify key determinants of MI, (ii) compare multiple classical Long Short-Term Memory (LSTM) architectures against a novel Quantum LSTM model embedding a Variational Quantum Circuit (VQC) directly within the LSTM gating mechanism, and (iii) evaluate the feasibility of quantum-enhanced sequential learning on small, heterogeneous healthcare datasets.</p><p><strong>Methods: </strong>Two public datasets were used: a global fertility rate time series (1960-2020) and an EHR-derived male fertility dataset (<i>n</i> = 100, 10 features). After preprocessing (scaling, encoding, multicollinearity checks, and class-imbalance correction), several classical LSTM variants and the proposed Quantum LSTM were trained and validated using 5-fold cross-validation, repeated random train-test splits, and bootstrap resampling. Performance was assessed via accuracy, precision, recall, F1-score, and computational time, with statistical significance evaluated using Friedman and Wilcoxon signed-rank tests. SHAP (SHapley Additive exPlanations) was applied for feature-level and model-level interpretability.</p><p><strong>Results: </strong>Among classical models, unilateral LSTM performed most consistently (91.2% accuracy on fertility-rate data; 92.1% on male-fertility data). The Quantum LSTM achieved the highest accuracy on both datasets (92.6% and 93.8% respectively), a modest but statistically significant improvement (Wilcoxon <i>p</i> = 0.031 and <i>p</i> = 0.024; Cohen's <i>d</i> = 0.42-0.48) with narrower bootstrap confidence intervals, indicating greater stability. SHAP analysis identified daily sitting duration and age as the most influential predictors of male fertility outcomes, followed by season and alcohol consumption frequency, with clinical history variables contributing comparatively less.</p><p><strong>Discussion: </strong>These findings demonstrate the feasibility of embedding quantum circuits within LSTM gating for small-scale healthcare prediction tasks, yielding incremental rather than transformative gains over classical architectures. Observed associations are exploratory and non-causal, and given the limited sample size (<i>n</i> = 100), single-center source, and simulator-based quantum execution, results should be interpreted as hypothesis-generating rather than clinically conclusive. Thi","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1853728"},"PeriodicalIF":4.6,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13672009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.","authors":"Aleksandra Porjazoska Kujundziski","doi":"10.3389/fmedt.2026.1943029","DOIUrl":"10.3389/fmedt.2026.1943029","url":null,"abstract":"<p><p>Conventional protocols for cancer treatment are usually accompanied by serious limitations, which can be addressed using innovative, minimally invasive methods, such as photothermal therapy (PTT). But, using this method as a standalone therapy is usually accompanied by uneven heat distribution within tumor tissues, and the risk of cancer recurrence. Integrating PTT with complementary therapeutic modalities can help prevent these issues. The development of nanophotothermal systems (NPTSs) as multipurpose, multimodal platforms for smart drug delivery has greatly broadened the therapeutic landscape of cancer treatment. Additionally, recent developments in bio-based and biocompatible nanomaterials have further expanded the potential of NPTSs in clinical applications. Furthermore, NPTSs combine therapeutic functionalities and diagnostic imaging, i.e., tracking modalities, such as photoacoustic, magnetic resonance, or fluorescence imaging, to provide real-time monitoring of drug delivery and treatment response. Translation of preclinical trials into clinical applications for these systems remains challenging due to issues such as toxicity, biodegradability, scalability, standardization, and regulatory approval. This narrative review analyzes two of the most versatile natural polysaccharides, chitosan (CS) and hyaluronic acid (HA), which have complementary physicochemical and biological properties. Covering the advantages of CS and HA for the application in multifuntional and multimodal nanophotothermal systems, their complementary effects, as well as their functional implications in therapeutic settings, this work aims to create a framework that will serve as a basis for further research in optimizing the design of multifunctional drug-delivery nanosystems, and at the same time, facilitate the transition of photothermal therapy from the bench to clinical use.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1943029"},"PeriodicalIF":4.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149168435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advances in electroactive materials-based strategies for promoting skin wound healing.","authors":"Haihong Ge, Xi Ren, Zeyuan Lei","doi":"10.3389/fmedt.2026.1919503","DOIUrl":"10.3389/fmedt.2026.1919503","url":null,"abstract":"<p><p>The loss of homeostasis of the local microenvironment is one of the processes encountered in chronic wound repair and is therefore a big challenge in clinical practice. Endogenous electric fields, being important biophysical cues in the wound bed, guide the direction of movement of the reparative cells, control the inflammatory process and help in the regeneration of the tissues. The classical external electrical stimulation equipment is strongly limited in the portability that can be offered and in the biocompatibility that can be ensured, which limits the wider clinical application of electroceutical approaches for wound care. Some recent developments in the field of electroactive materials give new methodologies for wound therapy by using electrical stimulation. In this article, first, the physiological process of wound closure and the origin and the properties of the endogenous electric fields are summarized. Then, it concentrates on three types of electroactive materials: conductive hydrogels that allow the effective conduction and enhancement of electrical signals through flexible interfaces; self-powered materials that generate their own power, e.g., by means of piezoelectricity or triboelectricity, transforming ambient mechanical energy into therapeutic electrical fields; and multifunctional composite materials that combine electrical stimulation together with antibacterial, exudate control, regulated drug delivery and immunomodulatory functions in a single system. Then the review explains in an ordered fashion the different mechanisms how the electric field can help wound repair, from the generation of directional signaling cues to the modulation of the inflammatory, proliferative and remodeling stages and also to the antimicrobial actions. Finally, it discusses existing barriers, i.e., the conflict between standard and personalized electrical stimulation parameters, the lack of long-term durability assessments and comprehensive biosafety evaluations. The review ends with some outlooks on the progress of future integrated closed-loop intelligent repair systems with sensing, decision-making and responsive functionalities.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1919503"},"PeriodicalIF":4.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149171051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Agathe Bricout, David Hardman, Scott Inglis, Stephen Pye, Carmel M Moran
{"title":"Beyond segmentation accuracy: understanding model reliability and failure modes in ultrasound image analysis.","authors":"Agathe Bricout, David Hardman, Scott Inglis, Stephen Pye, Carmel M Moran","doi":"10.3389/fmedt.2026.1918432","DOIUrl":"10.3389/fmedt.2026.1918432","url":null,"abstract":"<p><p>Segmentation of ultrasound images is complex, and although deep learning has improved automation, trust remains limited, restricting adoption. Interpretability methods may help reveal model behaviours and failure modes, supporting more trustworthy AI systems. A U-Net with a ResNet-18 backbone was trained to segment pipes in images of the Edinburgh Pipe Phantom acquired using ten ultrasound probes (<i>N</i> = 162). Performance was assessed using five-fold cross-validation. Predictive entropy and variance across 20 Monte Carlo dropout forward passes were used as approximations of data-related and model-related uncertainty. Calibration was assessed using the Brier score and expected calibration error (ECE). Input-gradient saliency and Grad-CAM maps from four encoder stages and the final decoder block were evaluated. For exploratory prospective quality control, complete empty-mask failures were assessed directly from model output, while non-empty predictions were classified retrospectively using reference-based performance criteria and reference-free uncertainty and morphological features were evaluated as candidate indicators. The model achieved a Dice score of 0.81 ± 0.03 and an HD95 of 11.98 ± 3.39. Seven segmentation errors were identified: three complete failures in which no foreground mask was predicted and four non-empty predictions in which the incorrect pipe was segmented. Dice score was associated with the Brier score (Spearman <i>ρ</i> = -0.96) and ECE (<i>ρ</i> = -0.72), whereas predictive entropy and Monte Carlo dropout variance showed weak associations with segmentation performance (|<i>ρ</i>| < 0.4). In selected failure examples, uncertainty and activation sometimes overlapped the reference pipe region despite incorrect segmentation. Complete empty-mask failures were deterministically identifiable from the model output, whereas the evaluated reference-free indicators showed limited ability to identify poor-quality non-empty segmentations. Within this phantom dataset and model configuration, calibration metrics were more closely associated with segmentation quality than the evaluated uncertainty approximations. Attention and uncertainty maps provided complementary descriptive information about selected errors, but indicated spatial sensitivity rather than causal model reasoning. Simple output checks enabled deterministic identification of complete segmentation failures; however, the evaluated reference-free indicators were insufficient for validated prospective identification of subtler non-empty errors. These findings support multimodal model evaluation for EPP segmentation while emphasising the need for validation on independent datasets, devices and architectures in future studies.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1918432"},"PeriodicalIF":4.6,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13642736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149139977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}